Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology
Rev. bras. ter. intensiva; 32 (2), 2020
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Coronavirus Infections/drug therapy, Aminoquinolines/therapeutic use, Oseltamivir/therapeutic use, Lopinavir/therapeutic use, Ritonavir/therapeutic use, Adrenal Cortex Hormones/therapeutic use, Heparin/therapeutic use, Anti-Bacterial Agents/therapeutic use, Betacoronavirus/drug effects, Pneumonia, Viral/drug therapy, Pandemics/prevention & control